The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 312-314

  Trulson, A ^a   Nilsson, S ^a   Venge, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; Chemiluminescence; ECP; Eosinophils; EPX

Indexed keywords

ALPHANATIVE; EOSINOPHIL CATIONIC PROTEIN; PEROXIDASE; PROTEIN X; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 2; TAMAXIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; KIDNEY CARCINOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030765161     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2203035.x     Document Type: Article

References (12)

1. Atzpodien, J., Körfer, A., Franks, C.R., Poliwoda, H. & Kirchner, H. (1990) Home therapy with recombinant interleukin-2 and interferon alpha 2b in advanced human malignancies. Lancet, 335, 1509-1512.
2. Fabian, I., Kravstov, V., Elis, A., Gurevitch, O., Ackerstein, A., Slavin, S. & Nalger, A. (1994) Eosinophil activation in postautologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-α2A immunotherapy. Leukemia, 8, 379-384.
3. Hansel, T.T., De Vries, J.M., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K. & Walker, C. (1991) An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. Journal of Immunological Methods, 145, 105-110.
4. Huland, E. & Huland, H. (1992) Tumour-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. Journal of Cancer Research and Oncology, 118, 463-467.
5. Karawajczyk, M., Pauksen, K., Peterson, C.G.B., Eklund, E. & Venge, P. (1995) The differential release of eosinophil granule proteins: study on patients with acute bacterial and viral infections. Clinical and Experimental Allergy, 25, 713-719.
6. Kita, H., Weiler, D.A., Abu-Ghazaleh, R., Sanderson, C.J. & Gleich, G.J. (1992) Release of granule proteins from eosinophils cultured with IL-5. Journal of Immunology, 149, 629-635.
7. Roberts, R.L., Bonnie, J., Ank, B.A. & Stiehm, E.R. (1991) Human eosinophils are more toxic than neutrophils in antibody-independent killing. Journal of Allergy and Clinical Immunology, 87, 1105-11015.
8. Sedgwick, J.B., Frick, W.E., Sondel, P.M., Hank, J.A., Borden, E. & Busse, W.W. (1990) The appearance of hypodense eosinophils during interleukin-2 treatment. Journal of Allergy and Clinical Immunology, 85, 557-566.
9. Silberstein, D.S. & David, J.R. (1986) Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proceedings of the National Academy of Sciences of the United States of America, 83, 1055-1059.
10. Venge, P. & Peterson, C.G.B. (1989) Eosinophil biochemistry and killing mechanisms. Eosinophils in Asthma (ed. by J. Morley and I. Colditz), pp. 163-177. Academic Press, New York.
11. Weller, P. (1991) The immunology of eosinophils. New England Journal of Medicine, 324, 1110-1118.
12. Woschnagg, C., Rak, S. & Venge, P. (1996) Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients. Clinical and Experimental Allergy, 26, 1064-1072.